Makoto Murata
Otsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications
Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.
Journal: Cytotherapy
Published: January 11, 2026
Successful treatment of post-transplant steroid-refractory idiopathic pneumonia syndrome with etanercept and mycophenolate mofetil
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025
BRD9 depletion-mediated ALOX5 upregulation via chromatin dysregulation induces ferroptosis in SF3B1-mutant hematopoiesis.
Journal: International journal of hematology
Published: August 18, 2025
The role of HLA transcription in unrelated hematopoietic cell transplantation.
Journal: Blood advances
Published: July 31, 2025
Risk Stratification Using Dynamic International Prognostic Scoring System and Splenomegaly in Myelofibrosis Treated with Pretransplant JAK Inhibitors.
Journal: Transplantation and cellular therapy
Published: July 21, 2025
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.
Journal: American journal of hematology
Published: June 20, 2025
High-Risk Human Leukocyte Antigen Mismatch Combinations Responsible for Severe Acute Graft-Versus-Host Disease in Cord Blood Transplantation.
Journal: Transplantation and cellular therapy
Published: May 20, 2025
Complete response of musculoskeletal chronic GVHD achieved with extracorporeal photopheresis therapy
Complete response of musculoskeletal chronic GVHD achieved with extracorporeal photopheresis therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 11, 2025
Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.
Journal: Journal for immunotherapy of cancer
Published: April 16, 2025
Efficacy of 5-hydroxytryptamine 3 receptor antagonists versus metoclopramide for preventing nausea and vomiting during azacitidine chemotherapy in patients with myelodysplastic syndromes or acute leukemia: a retrospective observational study.
Journal: Journal of pharmaceutical health care and sciences
Published: March 14, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of Ruxolitinib.
Journal: American journal of hematology
Published: February 20, 2025
Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study.
Journal: Cytotherapy
Published: February 17, 2025
Last Updated: 09/26/2026